Cancer

INDICATION: Sarcoma

Cell culture and mouse studies suggest combining Mekinist trametinib with IGF1R inhibitors could help treat PAX3-PAX7 fusion-negative rhabdomyosarcoma. Screening of a panel of

Read the full 246 word article

User Sign In